HomeCompaniesProfile

Engage Bio

Potent, durable, and redosable non-viral genetic medicines 

Company Size

6 - 10 employees

Year Founded

2021

About Engage Bio

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine.

In 2026 Engage was acquired by Eli Lilly.

Founders & Key People

Will Olsen

Will Olsen

Founder, Engage Bio

Kathryn Kwant

Kathryn Kwant

Founder, Engage Bio

Share This Profile

More Companies

Dashworks

Your team's intelligent start page.

91Squarefeet

AI Powered Construction Management Software

Felix Biotechnology

We’re creating programmable therapies

Tablevibe

All-in-one digital ordering system for restaurants

HomeBreeze

The fastest and easiest way to make home upgrades

PNOĒ

Enabling health professionals to prescribe clinical-grade wellness…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Connect with Us

Discover More

© Copyright 2026 BEAMSTART. All Rights Reserved.